Skip to main content
Journal cover image

Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.

Publication ,  Journal Article
de Boer, YS; Kosinski, AS; Urban, TJ; Zhao, Z; Long, N; Chalasani, N; Kleiner, DE; Hoofnagle, JH; Drug-Induced Liver Injury Network,
Published in: Clin Gastroenterol Hepatol
January 2017

BACKGROUND & AIMS: Drug-induced liver injury (DILI) has features similar to those of other liver diseases including autoimmune hepatitis (AIH). We aimed to characterize the clinical and autoimmune features of liver injury caused by nitrofurantoin, minocycline, methyldopa, or hydralazine. METHODS: We analyzed data from 88 cases of DILI attributed to nitrofurantoin, minocycline, methyldopa, or hydralazine included in the Drug-Induced Liver Injury Network prospective study from 2004 through 2014. Sera were collected from patients at baseline and follow-up examination and tested for levels of immunoglobulin G (IgG), antibodies to nuclear antigen (ANA), smooth muscle (SMA), and soluble liver antigen (SLA). An autoimmune score was derived on the basis of increases in levels of IgG, ANA, SMA, and SLA (assigned values of 0, 1+, or 2+). AIH-associated HLA-DRB1*03:01 and HLA-DRB1*04:01 allele frequencies were compared with those of the general population (controls). RESULTS: Of the 88 cases, 80 were women (91%), 74% had hepatocellular injury, and 25% had severe injury. At the onset of DILI, 39% of cases had increased levels of IgG, 72% had increased levels of ANA, 60% had increased levels of SMA, and none had increases in SLA. A phenotype of autoimmunity (autoimmune score ≥2) was observed in 82% of cases attributed to nitrofurantoin and 73% of cases attributed to minocycline (73%) but only 55% of cases attributed to methyldopa and 43% of cases attributed to hydralazine (P = .16 for nitrofurantoin and minocycline vs methyldopa and hydralazine). We observed a decrease in numbers of serum samples positive for ANA (P = .01) or SMA (P < .001) and in autoimmune scores (P < .001) between DILI onset and follow-up. Similar percentages of patients with DILI had HLA-DRB1*03:01 (15%) and HLA-DRB1*04:01 (9%) as controls (12% and 9%, respectively). CONCLUSIONS: In analysis of data from the DILIN prospective study, we found that most cases of DILI attributed to nitrofurantoin or minocycline and about half of cases that were due to methyldopa and hydralazine have a phenotype of autoimmunity similar to AIH. These features decrease with recovery of the injury and are not associated with the typical HLA alleles found in patients with idiopathic AIH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

January 2017

Volume

15

Issue

1

Start / End Page

103 / 112.e2

Location

United States

Related Subject Headings

  • Young Adult
  • Severity of Illness Index
  • Prospective Studies
  • Middle Aged
  • Male
  • Longitudinal Studies
  • Humans
  • Hepatitis, Autoimmune
  • HLA Antigens
  • Gastroenterology & Hepatology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
de Boer, Y. S., Kosinski, A. S., Urban, T. J., Zhao, Z., Long, N., Chalasani, N., … Drug-Induced Liver Injury Network, . (2017). Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol, 15(1), 103-112.e2. https://doi.org/10.1016/j.cgh.2016.05.043
Boer, Ynto S. de, Andrzej S. Kosinski, Thomas J. Urban, Zhen Zhao, Nanye Long, Naga Chalasani, David E. Kleiner, Jay H. Hoofnagle, and Jay H. Drug-Induced Liver Injury Network. “Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.Clin Gastroenterol Hepatol 15, no. 1 (January 2017): 103-112.e2. https://doi.org/10.1016/j.cgh.2016.05.043.
de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, et al. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol. 2017 Jan;15(1):103-112.e2.
de Boer, Ynto S., et al. “Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.Clin Gastroenterol Hepatol, vol. 15, no. 1, Jan. 2017, pp. 103-112.e2. Pubmed, doi:10.1016/j.cgh.2016.05.043.
de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH, Drug-Induced Liver Injury Network. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol. 2017 Jan;15(1):103-112.e2.
Journal cover image

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

January 2017

Volume

15

Issue

1

Start / End Page

103 / 112.e2

Location

United States

Related Subject Headings

  • Young Adult
  • Severity of Illness Index
  • Prospective Studies
  • Middle Aged
  • Male
  • Longitudinal Studies
  • Humans
  • Hepatitis, Autoimmune
  • HLA Antigens
  • Gastroenterology & Hepatology